Combining a targeted drug with hormone therapy substantially extends survival
Menlo Therapeutics Announces Results from a Phase 2 Clinical Trial of Serlopitant for the Treatment of Refractory Chronic Cough
REDWOOD CITY, Calif., Oct. 08, 2018 (GLOBE NEWSWIRE) — Menlo
Neoadjuvant combination checkpoint blockade trial yields high response rates for patients with stage 3 melanoma
Combination checkpoint blockade before surgery (neoadjuvant therapy) produced a high
Breakthrough weight-loss drug ‘reduces the risk of diabetes’ by 19%
Breakthrough twice-a-day weight-loss pill ‘reduces the risk of diabetes by
Researchers deploy novel clinical trial regimen for glioblastoma
Combating glioblastoma remains a major challenge due the complex nature
Hope for a cancer vaccine as scientists cure melanoma in mice
Hope for a cancer vaccine as scientists cure skin melanoma
Orphazyme Announces Enrollment of First Patient in Phase III Clinical Trial of Arimoclomol for ALS
Copenhagen, August 10, 2018 – Orphazyme A/S, a biopharmaceutical company
Otonomy Initiates Phase 3 Clinical Trial of Otividex in Ménière’s Disease
SAN DIEGO, July 26, 2018 (GLOBE NEWSWIRE) — Otonomy, Inc.
Could your gut microbes hinder your cancer treatment? A new first-in-human trial investigates
Could the poop of some cancer patients hold the key
KemPharm Announces Top Line Results from KP415.E01 Efficacy and Safety Trial in Children With ADHD
CORALVILLE, Iowa, July 09, 2018 (GLOBE NEWSWIRE) — KemPharm, Inc.